Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

1. Muñoz, R.
2. Arias, Y.
3. Ferreras, J.M.
4. Rojo, M.A.
5. Gayoso, M.J.
6. Nocito, M.
7. Benitez, J.
8. Jiménez, P.
9. Bernabéu, C.
10. Girbés, T.